News

Guillain-Barré Syndrome (GBS) poses a diagnostic challenge due to its misleading symptoms, the lack of a definitive test, and ...
A study published in July 2025 issue of Journal of Neurology explored how genetic variability in the FCGR2/3 locus, which ...
A rare Guillain-Barré syndrome recurrence caused nausea with no motor symptoms but was treated successfully with intravenous ...
Guillain-Barre syndrome has gained attention due to a possible link with COVID-19. Experts what the disease is as well as causes, symptoms and treatment.
Acute flaccid paralysis in children is a medical emergency that can progress to respiratory failure within hours or days, ...
Guillain-Barré syndrome (GBS) is a rare, autoimmune disease that sees the body's own immune system damages the nerves. It causes muscle weakness and sometimes paralysis, the U.S. Centers for ...
Annexon offers speculative upside with Tanruprubart, targeting Guillain-Barré Syndrome's unmet needs. Click here to read my ...
A new study indicates that COVID-19 is associated with an elevated risk of a rare disorder, Guillain-Barré syndrome, within six weeks after infection with the virus.
Guillain-Barré Syndrome (GBS) is a rare neuromuscular condition that can cause rapid paralysis. Diagnosing GBS is challenging, and misdiagnosis can lead to delayed treatment and potentially long ...
Guillain-Barré Syndrome (GBS), a rare autoimmune condition, has claimed another life in Pune, Maharashtra. Earlier this week, the state reported the first death, sharing that the number of cases ...
Guillain-Barré syndrome, sometimes called GBS, is an autoimmune disorder in which the body's immune system attacks the nerves, causing muscle weakness and occasionally paralysis.
A Houston woman who developed the rare neurological condition Guillain-Barré syndrome (GBS) after receiving the one-dose Johnson & Johnson COVID-19 vaccine said she would get the shot again ...